Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paweł Knapp

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Ginekologia Polska|November 3, 2004
[Life style, Chlamydia trachomatis infection, bacterial vaginosis and their impact on the frequency of cervical lesions]Tomasz Zbroch, Paweł Knapp, Ewa Błońska, et al.
Journal of Clinical Medicine|March 6, 2021
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-AnalysisBeata Gąsowska-Bajger, Agnieszka Gąsowska-Bodnar, Paweł Knapp, et al.
Biomed Research International|June 13, 2019
Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive SystemPaweł Knapp, Karolina Chomicz, Magdalena Świderska, et al.
Przeglad Lekarski|April 27, 2005
[Mass screening programs running in Podlaski region based on standards existing in European Union-- actual status and future perspectives]Piotr Knapp, Tomasz Zbroch, Paweł Knapp, et al.
Molecules (Basel, Switzerland)|April 12, 2022
The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial CancerJakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, et al.
PPAR Research|March 27, 2012
Altered peroxisome-proliferator activated receptors expression in human endometrial cancerPaweł Knapp, Adrian Chabowski, Agnieszka Błachnio-Zabielska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|March 10, 2007
[The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients]Sławomir ławicki, Małgorzata Czygier, Ewa Gacuta-Szumarska, et al.
Gynecologic Oncology|August 13, 2017
Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancerPaweł Knapp, Lubomir Bodnar, Agnieszka Błachnio-Zabielska, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Obesity and Energy Substrate Transporters in Ovarian Cancer-ReviewMarta Baczewska, Klaudia Bojczuk, Adrian Kołakowski, et al.
Kardiologia Polska|April 9, 2005
[Peripartum cardiomyopathy--a case report]Małgorzata Knapp, Grazyna Lachota-Korecka, Paweł Knapp, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Ginekologia Polska|November 3, 2004
[Life style, Chlamydia trachomatis infection, bacterial vaginosis and their impact on the frequency of cervical lesions]Tomasz Zbroch, Paweł Knapp, Ewa Błońska, et al.
Journal of Clinical Medicine|March 6, 2021
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-AnalysisBeata Gąsowska-Bajger, Agnieszka Gąsowska-Bodnar, Paweł Knapp, et al.
Biomed Research International|June 13, 2019
Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive SystemPaweł Knapp, Karolina Chomicz, Magdalena Świderska, et al.
Przeglad Lekarski|April 27, 2005
[Mass screening programs running in Podlaski region based on standards existing in European Union-- actual status and future perspectives]Piotr Knapp, Tomasz Zbroch, Paweł Knapp, et al.
Molecules (Basel, Switzerland)|April 12, 2022
The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial CancerJakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, et al.
PPAR Research|March 27, 2012
Altered peroxisome-proliferator activated receptors expression in human endometrial cancerPaweł Knapp, Adrian Chabowski, Agnieszka Błachnio-Zabielska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|March 10, 2007
[The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients]Sławomir ławicki, Małgorzata Czygier, Ewa Gacuta-Szumarska, et al.
Gynecologic Oncology|August 13, 2017
Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancerPaweł Knapp, Lubomir Bodnar, Agnieszka Błachnio-Zabielska, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Obesity and Energy Substrate Transporters in Ovarian Cancer-ReviewMarta Baczewska, Klaudia Bojczuk, Adrian Kołakowski, et al.
Kardiologia Polska|April 9, 2005
[Peripartum cardiomyopathy--a case report]Małgorzata Knapp, Grazyna Lachota-Korecka, Paweł Knapp, et al.
Pageof 4